Monitoring9 min readUpdated 2025-04-03

    GLP-1 Weekly Check-In: Your Self-Assessment Template

    Use this weekly GLP-1 check-in template to track your semaglutide or tirzepatide progress. Monitor weight, side effects, appetite, energy, and treatment effectiveness.

    5-Minute Weekly Ritual

    Patients who complete weekly check-ins are significantly more likely to reach their weight loss goals. This quick self-assessment keeps you accountable and gives your provider actionable data.

    Your Weekly Check-In Template

    Complete this template every week on the same day, ideally in the morning before eating. Whether you use semaglutide or tirzepatide, consistent tracking drives better outcomes.

    1. Physical Measurements

    Record current weight, waist circumference, and any other measurements you track. Note the time of day and conditions (before/after eating, hydration status).

    2. Side Effects Check

    Rate nausea (0-10), note any constipation, diarrhea, headaches, or fatigue. Track when side effects occur relative to your injection day and what helps relieve them.

    3. Appetite and Satiety

    Rate your average appetite (1-10, where 10 is ravenous). Note food noise levels, cravings, and how full you feel after meals. Track which days appetite suppression is strongest.

    4. Energy and Mood

    Rate energy (1-10) and overall mood. Note sleep quality, exercise completed, and general well-being. These factors often improve before scale changes appear.

    5. Medication Notes

    Record injection date, time, site, and current dose. Note any injection site reactions. Flag questions for your next provider visit.

    Reading Your Weekly Trends

    On Track Signs

    • Losing 0.5-2 lbs per week average
    • Reduced appetite most days
    • Side effects stable or improving
    • Energy levels maintained or improved

    Talk to Your Provider

    • No weight change for 4+ consecutive weeks
    • Side effects worsening over time
    • Appetite returning to pre-treatment levels
    • Significant mood or energy decline

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your treatment plan.

    Frequently Asked Questions

    What day should I do my weekly GLP-1 check-in?

    Choose the day before your injection day. This captures data at the end of your medication cycle when levels are lowest, giving you consistent comparisons week to week.

    How long should a weekly check-in take?

    A thorough weekly check-in takes 5-10 minutes. Weigh yourself, record measurements, note side effects, rate your appetite and energy, and jot down any questions for your provider.

    What if my numbers don't change one week?

    Weekly plateaus are completely normal on GLP-1 medications. Weight loss is rarely linear. Look at 4-week trends rather than individual weeks. Water retention, hormonal cycles, and meal timing all affect weekly readings.

    Should I share my weekly check-in data with my doctor?

    Yes, bring your check-in log to appointments or share it via your patient portal. This data helps providers make better dose adjustment decisions and identify patterns you might miss.

    Start Your GLP-1 Journey with Expert Support

    Compounded semaglutide from $99/mo or tirzepatide from $125/mo with provider monitoring.

    View Treatment Options

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: January 20, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook
    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Create a comprehensive monthly GLP-1 progress report. Compile weight trends, side effects, measurements, and lab results to optimize your semaglutide or tirzepatide treatment.

    Learn the best techniques for taking GLP-1 weight loss progress photos. Consistent lighting, angles, and timing help you accurately track semaglutide and tirzepatide results.

    Learn how to accurately measure your waist circumference while on GLP-1 medications. Waist measurements often show progress before the scale on semaglutide or tirzepatide.

    Learn how to take accurate body measurements while on GLP-1 medications. Track waist, hips, arms, thighs, and chest to see the full picture of your semaglutide or tirzepatide results.

    Start your GLP-1 journey — from $99/mo

    Get Started